Trials / Terminated
TerminatedNCT00783796
SPIRIT Small Vessel Registry
Spirit Small Vessel Registry (SPIRIT SV)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and effectiveness of the 2.25 mm XIENCE V® Everolimus Eluting Coronary Stent System (XIENCE V® EECSS) in improving coronary luminal diameter in subjects with ischemic heart disease due to a maximum of two de novo native coronary artery lesions in small vessels, each in a different epicardial vessel.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 2.25 mm XIENCE V® Everolimus Eluting Coronary Stent System | Treatment of a maximum of two de novo native coronary artery lesions in small vessels. |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2010-10-01
- Completion
- 2013-12-01
- First posted
- 2008-11-03
- Last updated
- 2019-05-08
- Results posted
- 2012-01-05
Locations
34 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00783796. Inclusion in this directory is not an endorsement.